Novartis | NOVN - Market Capitalization

Stock Price
121.78
Daily Change
0.34 0.28%
Monthly
-4.40%
Yearly
23.72%
Q1 Forecast
118.31

Novartis reported $249.25B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Alcon AG USD 32.44B 1.36B Mar/2026
Almirall EUR 2.66B 102.29M Mar/2026
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Autolus Therapeutics Ltd USD 433.81M 0 Mar/2026
Bayer EUR 36.89B 535.42M Mar/2026
Biogen USD 25.82B 5.28B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Fresenius EUR 28.24B 653.36M Mar/2026
Fresenius Medical Care EUR 11.68B 275.81M Mar/2026
Galapagos EUR 1.89B 49.73M Mar/2026
Genmab DKK 80.88B 7.82B Jun/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
GRIFOLS EUR 4.43B 3.06B Mar/2026
Hikma Pharmaceutical USD 2.92B 1.72B Mar/2026
J&J USD 500.24B 67.44B Dec/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 47.3B 6B Mar/2026
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 265.66B 9.48B Sep/2025
Novartis USD 246.07B 11.81B Sep/2025
Novo Nordisk A/S DKK 1.45T 86.62B Dec/2025
Orion EUR 8.94B 243.74M Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Philips EUR 22.38B 192.58M Dec/2025
Recordati EUR 10.15B 660.84M Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 32.47B 4.91B Jun/2025